Patents Assigned to Biogen Idec
  • Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
    Patent number: 8329172
    Abstract: New combined therapeutic regimens for treatment of B-cell lymphomas are disclosed which comprise in particular administration of anti-CD20 antibodies to patients having low-, intermediate- or high-grade non-Hodgkins lymphomas.
    Type: Grant
    Filed: August 18, 2007
    Date of Patent: December 11, 2012
    Assignee: Biogen Idec
    Inventor: Antonio J. Grillo-López